Eloralintide: The New Weight-Loss Drug Getting Researchers Excited
Meet eloralintide, an investigational weight-loss medication targeting the amylin pathway. Explore its promising clinical trial results, how it differs from GLP-1 medications, and why researchers are studying its combination with tirzepatide.